# RAPH (Raphael Pharmaceutical Inc.) - SEC EDGAR Financial Statements

> Raphael Pharmaceutical Inc. reported $7.0K in total assets and a net loss of $980K through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RAPH
- Markdown: https://convexityos.com/fundamentals/RAPH.md
- SEC CIK: 0001415397
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001415397&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$927K | Operating profit |
| Net Income | FY 2025 | -$980K | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.05 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $631K | $776K | $569K | $1.18M | $776K | $461K |
| **Operating Income** | -$1.25M | -$1.51M | -$1.33M | -$3.32M | -$1.63M | -$706K |
| **Net Income** | -$1.28M | -$1.52M | -$1.34M | -$3.36M | -$1.62M | -$718K |
| Basic EPS | $0.07 | $0.08 | $0.08 | $0.23 | $0.14 | $0.07 |
| **Diluted EPS** | $0.07 | $0.08 | $0.08 | $0.23 | $0.14 | $0.07 |
| Basic Shares Outstanding | 19.6M | 18.7M | 16.7M | 14.3M | 11.2M | 9.5M |
| Diluted Shares Outstanding | 19.6M | 18.7M | 16.7M | 14.3M | 11.2M | 9.5M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $40K | $37K | $345K | $73K | $141K | $72K | $211K | $162K |
| **Operating Income** | -$199K | -$223K | -$254K | -$251K | -$315K | -$425K | -$394K | -$319K |
| Interest Expense | -- | $3.0K | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$223K | -$229K | -$273K | -$255K | -$322K | -$429K | -$395K | -$326K |
| Basic EPS | $0.01 | $0.01 | -- | $0.01 | $0.02 | $0.02 | -- | $0.01 |
| **Diluted EPS** | $0.01 | $0.01 | -- | $0.01 | $0.02 | $0.02 | -- | $0.01 |
| Basic Shares Outstanding | 20.2M | 20.2M | -- | 19.6M | 19.6M | 19.6M | -- | 18.7M |
| Diluted Shares Outstanding | 20.2M | 20.2M | -- | 19.6M | 19.6M | 19.6M | -- | 18.7M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $19K | $230K | $288K | $153K | $95K |
| **Cash & Short-Term Investments** | -- | $19K | $230K | $288K | $153K | $95K |
| Accounts Receivable, Net | $2.0K | $2.0K | -- | -- | -- | -- |
| Other Current Assets | $6.0K | $6.0K | $7.0K | $43K | $269K | $228K |
| **Total Current Assets** | $51K | $25K | $237K | $331K | $422K | $323K |
| Property, Plant & Equipment, Net | $2.0K | $2.0K | $2.0K | -- | -- | -- |
| Intangible Assets | -- | -- | $2.0K | $2.0K | -- | -- |
| **Total Non-Current Assets** | $2.0K | $2.0K | $2.0K | $2.0K | $0 | $0 |
| **Total Assets** | $53K | $27K | $239K | $333K | $422K | $323K |
| Accounts Payable | $163K | $125K | $69K | $72K | $107K | $9.0K |
| Short-Term Debt | -- | $41K | -- | -- | -- | $357K |
| **Total Current Liabilities** | $1.49M | $769K | $132K | $227K | $294K | $366K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $1.49M | $769K | $132K | $227K | $294K | $366K |
| **Total Debt (incl. Leases)** | -- | $41K | -- | -- | -- | $357K |
| Common Stock | $202K | $187K | $185K | $157K | $130K | $95K |
| Retained Earnings | -$10.17M | -$8.89M | -$7.37M | -$6.03M | -$2.67M | -$1.04M |
| **Total Stockholders' Equity** | -$1.43M | -$742K | $107K | $106K | $128K | -$43K |
| Total Equity | -$1.43M | -$742K | $107K | $106K | $128K | -$43K |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | -- | $20K | $50K | $19K | $40K |
| **Cash & Short-Term Investments** | -- | -- | -- | -- | $20K | $50K | $19K | $40K |
| Accounts Receivable, Net | -- | -- | $2.0K | -- | -- | -- | $2.0K | -- |
| Other Current Assets | $5.0K | -- | $6.0K | $2.0K | $8.0K | $41K | $6.0K | $9.0K |
| **Total Current Assets** | $6.0K | $1.0K | $51K | $5.0K | $28K | $91K | $25K | $49K |
| Property, Plant & Equipment, Net | $1.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| **Total Non-Current Assets** | $1.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| **Total Assets** | $7.0K | $3.0K | $53K | $7.0K | $30K | $93K | $27K | $51K |
| Accounts Payable | -- | -- | $163K | -- | -- | -- | $125K | -- |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $41K | -- |
| **Total Current Liabilities** | $1.89M | $1.67M | $1.49M | $1.27M | $1.08M | $827K | $769K | $667K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $1.89M | $1.67M | $1.49M | $1.27M | $1.08M | $827K | $769K | $667K |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | -- | $41K | -- |
| Common Stock | $202K | $202K | $202K | $196K | $196K | $9.0K | $187K | $187K |
| Retained Earnings | -$10.62M | -$10.40M | -$10.17M | -$9.89M | -$9.64M | -$9.32M | -$8.89M | -$8.43M |
| **Total Stockholders' Equity** | -$1.89M | -$1.66M | -$1.43M | -$1.26M | -$1.05M | -$734K | -$742K | -$616K |
| Total Equity | -$1.89M | -$1.66M | -$1.43M | -$1.26M | -$1.05M | -$734K | -$742K | -$616K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.28M | -$1.52M | -$1.34M | -$3.36M | -$1.62M | -$718K |
| Stock-Based Compensation | $245K | $350K | $200K | $2.29M | -- | -- |
| Change in Payables | -- | -- | -$190K | $102K | $234K | -- |
| **Operating Cash Flow** | -$210K | -$532K | -$1.20M | -$759K | -$1.42M | -$779K |
| Capital Expenditure | -- | -- | -- | -$2.0K | -- | -- |
| **Free Cash Flow** | -- | -- | -- | -$761K | -- | -- |
| **Investing Cash Flow** | -- | -- | -- | -$2.0K | -- | -- |
| Common Stock Issued | $243K | $280K | $1.15M | -- | -- | -- |
| **Financing Cash Flow** | $236K | $321K | $1.15M | $896K | $1.48M | $824K |
| **Net Change in Cash** | $26K | -$211K | -$58K | $135K | $58K | $45K |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$223K | -$229K | -$273K | -$255K | -$322K | -$429K | -$395K | -$326K |
| Stock-Based Compensation | -- | -- | $1.0K | $39K | $8.0K | $197K | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | -- | -- | $249K |
| **Operating Cash Flow** | $0 | -$44K | $46K | -$17K | -$30K | -$209K | -$62K | -$80K |
| Common Stock Issued | -- | -- | $3.0K | $0 | $0 | $240K | $0 | $0 |
| **Financing Cash Flow** | -- | -- | -$4.0K | $0 | $0 | $240K | $41K | $0 |
| **Net Change in Cash** | $0 | -$44K | $42K | -$17K | -$30K | $31K | -$21K | -$80K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -1256.1% | -3167.9% | -1268.8% | -- |
| Return on Assets (ROA) | -2413.2% | -5625.9% | -562.3% | -1008.4% | -384.8% | -222.3% |
| Current Ratio | 0.03x | 0.03x | 1.80x | 1.46x | 1.44x | 0.88x |
| Quick Ratio | -- | 0.03x | 1.74x | 1.27x | 0.52x | 0.26x |
| EPS Growth (YoY) | -12.5% | 0.0% | -65.2% | +64.3% | +100.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -14000.0% | -35966.7% | -2413.2% | -20014.3% | -4906.7% | -1503.2% | -5625.9% | -2082.4% |
| Current Ratio | 0.00x | 0.00x | 0.03x | 0.00x | 0.03x | 0.11x | 0.03x | 0.07x |
| Quick Ratio | -- | -- | -- | -- | 0.02x | 0.06x | 0.03x | 0.06x |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -632.4% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -737.1% | -- |
| EPS Growth (YoY) | -50.0% | -50.0% | -- | 0.0% | +100.0% | -33.3% | -- | -75.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
